The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Why does obesity cause diabetes?
Open accessAbstract
The accumulation of an excessive amount of body fat can cause type 2 diabetes, and the risk of type 2 diabetes increases linearly with an increase in body mass index. Accordingly, the worldwide increase in the prevalence of obesity has led to a concomitant increase in the prevalence of type 2 diabetes. The cellular and physiological mechanisms responsible for the link between obesity and type 2 diabetes are complex and involve adiposity-induced alterations in β cell function, adipose tissue biology, and multi-organ insulin resistance, which are often ameliorated and can even be normalized with adequate weight loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It has also been shown to reduce both quality of life and life expectancy (2).”
From The Benefits of Exercise Training in Combination With Weight Loss Therapies (2025) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,061
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Cited by
Sorted by citations
Gastaldelli, A., Cusi, K., Fernández Landó, L., Bray, R., Brouwers, B., & Rodríguez, Á. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00070-5 · Cited by 513
Self-citationThe Role of Obesity in Type 2 Diabetes Mellitus—An Overview
Chandrasekaran, P., & Weiskirchen, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031882 · Cited by 582
Obesity, Inflammation, and Immune System in Osteoarthritis
Nedunchezhiyan, U., Varughese, I., Sun, A. R., Wu, X., Crawford, R., & Prasadam, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907750 · Cited by 507
Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463
Self-citationTirzepatide for Obesity Treatment and Diabetes Prevention
Jastreboff, A. M., le Roux, C. W., Stefanski, A., Aronne, L. J., Halpern, B., Wharton, S., Wilding, J. P. H., Perreault, L., Zhang, S., Battula, R., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2410819 · Cited by 462
MAFLD: How is it different from NAFLD?
Gofton, C., Upendran, Y., Zheng, M., & George, J. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0367 · Cited by 436
Lingvay, I., Cohen, R. V., Roux, C. W. L., & Sumithran, P. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01210-8 · Cited by 433
Diabetes mellitus—Progress and opportunities in the evolving epidemic
Abel, E. D., Gloyn, A. L., Evans‐Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Suszták, K., & Drucker, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.029 · Cited by 350
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s008 · Cited by 236
White adipocyte dysfunction and obesity-associated pathologies in humans
Hagberg, C. E., & Spalding, K. L. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00680-1 · Cited by 236
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s008 · Cited by 213
Blüher, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16263 · Cited by 247
Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
Vilariño‐García, T., Polonio-González, M., Pérez‐Pérez, A., Ribalta, J., Arrieta, F., Aguilar‐Diosdado, M., Obaya, J. C., Gimeno-Orna, J. A., Iglesias, P., Navarro, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042338 · Cited by 201
Singh, A. P., Shadangi, S., Gupta, P. K., & Rana, S. (2025) · Comprehensive physiology · doi:10.1002/cph4.70003 · Cited by 201
Animal models for type 1 and type 2 diabetes: advantages and limitations
Singh, R. K., Gholipourmalekabadi, M., & Shafikhani, S. H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1359685 · Cited by 188
Relevance of body composition in phenotyping the obesities
Salmón‐Gómez, L., Catalán, V., Frühbeck, G., & Gómez‐Ambrosi, J. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09796-3 · Cited by 187
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Huttasch, M., Roden, M., & Kahl, S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155937 · Cited by 169
Campbell, J. E., Müller, T. D., Finan, B., DiMarchi, R. D., Tschöp, M. H., & D’Alessio, D. A. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.010 · Cited by 149
Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes
Guo, W., Zhang, Z., Li, L., Liang, X., Wu, Y., Wang, X., Ma, H., Cheng, J., Zhang, A., Tang, P., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106355 · Cited by 135
Hepatic glucose metabolism in the steatotic liver
Scoditti, E., Sabatini, S., Carli, F., & Gastaldelli, A. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00888-8 · Cited by 134
Self-citationβ−Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives
Wess, J., Oteng, A., Rivera‐Gonzalez, O., Gurevich, E. V., & Gurevich, V. V. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000302 · Cited by 116
Dato, V. A., Lange, S., & Cho, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021211 · Cited by 117
Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes
Dhokte, S., & Czaja, K. (2024) · Nutrients · doi:10.3390/nu16071015 · Cited by 118
Diabetic Wound Repair: From Mechanism to Therapeutic Opportunities
Wang, R., Gu, S., Kim, Y. H., Lee, A., Lin, H., & Jiang, D. (2025) · MedComm · doi:10.1002/mco2.70406 · Cited by 118
Selective remodelling of the adipose niche in obesity and weight loss
Miranda, A. M. A., McAllan, L., Mazzei, G., Andrew, I., Davies, I., Ertuğrul, M. S., Kenkre, J. S., Kudo, H., Carrelha, J., Patel, B., et al. (2025) · Nature · doi:10.1038/s41586-025-09233-2 · Cited by 112
Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment
Pellegrini, V., Grotta, R. L., Carreras, F., Giuliani, A., Sabbatinelli, J., Olivieri, F., Berra, C., Ceriello, A., & Prattichizzo, F. (2024) · Cells · doi:10.3390/cells13191662 · Cited by 105
Peroxisomal regulation of energy homeostasis: Effect on obesity and related metabolic disorders
Kleiboeker, B. A., & Lodhi, I. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101577 · Cited by 96
Obesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction
Choi, W., Woo, G. H., Kwon, T., & Jeon, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199715 · Cited by 120
Buddhiraju, A., Kagabo, W., Khanuja, H. S., Oni, J. K., Nikkel, L. E., & Hegde, V. V. (2024) · The Journal of Arthroplasty · doi:10.1016/j.arth.2024.05.079 · Cited by 84
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
Abdul-Ghani, M. A., Maffei, P., & DeFronzo, R. A. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00127-x · Cited by 80
GLP-1 agonist to treat obesity and prevent cardiovascular disease: what have we achieved so far
Pedrosa, M. R., Franco, D. R., Gieremek, H. W., Vidal, C. M., Bronzeri, F., de Cassia Rocha, A., de Carvalho Cara, L. G., Fogo, S. L., & Eliaschewitz, F. G. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01062-2 · Cited by 68
Suryaningtyas, I. T., & Je, J. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.06.015 · Cited by 73
Spotlight on the Mechanism of Action of Semaglutide
Papakonstantinou, I. P., Tsioufis, K. P., & Katsi, V. K. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46120872 · Cited by 89
Marine-Derived Polysaccharides and Their Potential Health Benefits in Nutraceutical Applications
Carrasqueira, J., Bernardino, S. M. S. A., Bernardino, R., & Afonso, C. (2025) · Marine Drugs · doi:10.3390/md23020060 · Cited by 77
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s008 · Cited by 116
The Significance of Hypothalamic Inflammation and Gliosis for the Pathogenesis of Obesity in Humans
SEWAYBRICKER, L. E., Huang, A., Chandrasekaran, S., Melhorn, S. J., & Schur, E. A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac023 · Cited by 78
Coronell‐Tovar, A., Pardo, J. P., Rodríguez‐Romero, A., Sosa‐Peinado, A., Vásquez-Bochm, L. X., Cano‐Sánchez, P., Álvarez‐Añorve, L. I., & González‐Andrade, M. (2024) · FEBS Letters · doi:10.1002/1873-3468.14901 · Cited by 72
Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes
Cho, H., Lai, C.-C., Bonnavion, R., Alnouri, M. W., Wang, S., Roquid, K. A., Kawase, H., Campos, D., Chen, M., Weinstein, L. S., et al. (2025) · Science · doi:10.1126/science.adr4731 · Cited by 69
Bays, H. E., Bindlish, S., & Clayton, T. L. (2023) · Obesity Pillars · doi:10.1016/j.obpill.2023.100056 · Cited by 66
Szekeres, Z., Nagy, A., Jahner, K., & Szabados, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158214 · Cited by 67
Adipose–Muscle Crosstalk in Age-Related Metabolic Disorders: The Emerging Roles of Adipo-Myokines
Fang, P., She, Y., Yu, M., Min, W., Shang, W., & Zhang, Z. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101829 · Cited by 62
Dezfouli, R. A., Khonsari, N. M., Hosseinpour, A., Asadi, S., Ejtahed, H., & Qorbani, M. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01388-0 · Cited by 62
The adipocyte supersystem of insulin and cAMP signaling
Guilherme, A., Rowland, L. A., Wang, H., & Czech, M. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.07.009 · Cited by 59
The obesity pandemic and its impact on non-communicable disease burden
Hildebrand, S., & Pfeifer, A. (2025) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-025-03066-8 · Cited by 71
Myokines: Metabolic regulation in obesity and type 2 diabetes
Chen, Z.-T., Weng, Z.-X., Lin, J. D., & Meng, Z.-X. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae006 · Cited by 58
Halabitska, I., Бабинец, Л. С., Oksenych, V., & Kamyshnyi, O. (2024) · Biomedicines · doi:10.3390/biomedicines12081630 · Cited by 57
Michalopoulou, E., Thymis, J., Lampsas, S., Pavlidis, G., Katogiannis, K., Vlachomitros, D., Katsanaki, E., Kostelli, G., Pililis, S., Pliouta, L., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020428 · Cited by 69
Du, K., Umbaugh, D. S., Wang, L., Jun, J. H., Dutta, R. K., Oh, S., Ren, N., Zhang, Q., Ko, D. C., Ferreira, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57616-w · Cited by 61
Güney, C., Bal, N. B., & Akar, F. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18896 · Cited by 53
Zhang, X., Wang, Y., Li, Y., Gui, J., Mei, Y., Yang, X., Liu, H., Guo, L., Li, J., Lei, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61592-4 · Cited by 50
Hu, G., Ding, J., & Ryan, D. H. (2023) · Obesity · doi:10.1002/oby.23652 · Cited by 46
Understanding Adipose Tissue Dysfunction
Blüher, M. (2024) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes24013 · Cited by 55
Li, L., Xie, J., Zhang, Z., Xia, B., Li, Y., Lin, Y., Li, M., Wu, P., & Lin, L. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128873 · Cited by 44
Hazar, N., Jokar, M., Namavari, N., Hosseini, S., & Rahmanian, V. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1322072 · Cited by 47
Wang, G., Muñoz-Rojas, A. R., Spallanzani, R. G., Franklin, R. A., Benoist, C. O., & Mathis, D. J. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.002 · Cited by 47
IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches
Elahi, R., Nazari, M., Mohammadi, V., Esmaeilzadeh, K., & Esmaeilzadeh, A. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.03.009 · Cited by 48
Activin E–ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice
Adam, R. C., Pryce, D. S., Lee, J. S., Zhao, Y., Mintah, I. J., Min, S., Halasz, G., Mastaitis, J., Atwal, G. S., Aykul, S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309967120 · Cited by 44
Plant‐derived bioactive peptides: A comprehensive review
Kadam, D., Kadam, A., Köksel, F., & Aluko, R. E. (2024) · Sustainable Food Proteins · doi:10.1002/sfp2.1036 · Cited by 47
Anson, M., Henney, A. E., Broadwell, N., Zhao, S. S., Ibarburu, G. H., Lip, G. Y. H., Wilding, J. P. H., Cuthbertson, D. J., & Alam, U. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102777 · Cited by 44
Cho, Y. K., Yoon, Y. C., Im, H., Son, Y., Kim, M., Saha, A., Choi, C., Lee, J., Lee, S., Kim, J. H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31805-3 · Cited by 43
BACH1 controls hepatic insulin signaling and glucose homeostasis in mice
Jin, J., He, Y., Guo, J., Pan, Q., Wei, X., Chen, X., Qi, Z., Li, Q., Ma, S., Lin, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-44088-z · Cited by 45
Cho, Y., Kim, S., Kim, P.-K., Jo, M. J., Park, S.-E., Choi, Y., Jung, S. M., & Kang, H. J. (2025) · Biomolecules · doi:10.3390/biom15020291 · Cited by 49
Guan, H., Tian, J., Wang, Y., Niu, P., Zhang, Y., Zhang, Y., Fang, X., Miao, R., Yin, R., & Tong, X. (2024) · European journal of medical research · doi:10.1186/s40001-024-01739-1 · Cited by 55
Enteroendocrine cells: the gatekeepers of microbiome-gut-brain communication
Grundeken, E., & Aidy, S. E. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00810-x · Cited by 48
Enhancing adipose tissue plasticity: progenitor cell roles in metabolic health
Lecoutre, S., Rebière, C., Maqdasy, S., Lambert, M., Dussaud, S., Abatan, J. B., Dugail, I., Gautier, E. L., Clément, K., & Marcelin, G. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01071-y · Cited by 52
Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus
Rodríguez Jiménez, B., Rodríguez de Vera Gómez, P., Belmonte Lomas, S., Mesa Díaz, Á. M., Caballero Mateos, I., Galán, I., Morales Portillo, C., & Martínez-Brocca, M. A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1386542 · Cited by 39
“Adiposity is an independent risk factor for glycometabolism disorder, since fat accumulation affects insulin ’ s action by different mechanisms including insulin resistance in organs such as the liver and muscle tissue (46, 48).”
BackgroundCellular Senescence in Obesity and Associated Complications: a New Therapeutic Target
Narasimhan, A., Flores, R. R., Camell, C. D., Bernlohr, D., Robbins, P. D., & Niedernhofer, L. J. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01493-w · Cited by 40
Hu, D., Tan, M., Lu, D., Kleiboeker, B. A., Liu, X., Park, H., Kravitz, A. V., Shoghi, K. I., Tseng, Y., Razani, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41849-8 · Cited by 41
Loss of GPR75 protects against non-alcoholic fatty liver disease and body fat accumulation
Leeson-Payne, A. T. S., Iyinikkel, J., Malcolm, C., Lam, B., Sommer, N., Dowsett, G. K. C., de Morentin, P. B. M., Thompson, D., MacKenzie, A., Chianese, R., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.016 · Cited by 40
Carli, F., Sabatini, S., Gaggini, M., Sironi, A. M., Bedogni, G., & Gastaldelli, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914651 · Cited by 37
Self-citationWu, M., Lyu, Y., Xu, H., Luo, H., Yin, X., & Zheng, H. X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130007 · Cited by 36
Khunti, K., Schnecke, V., Haase, C. L., Harder-Lauridsen, N. M., Rathor, N., Matthiessen, K. S., & Morgen, C. S. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15154 · Cited by 36
Leptin Reduction as a Required Component for Weight Loss
Zhao, S., Li, N., Xiong, W., Li, G., He, S., Zhang, Z., Zhu, Q., Jiang, N., Ikejiofor, C., Zhu, Y., et al. (2023) · Diabetes · doi:10.2337/db23-0571 · Cited by 35
Self-citationBenák, D., Sevcikova, A., Holzerová, K., & Hlaváčková, M. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1500394 · Cited by 40
Noninvasive On-Skin Biosensors for Monitoring Diabetes Mellitus
Sedighi, A., Kou, T., Huang, H., & Li, Y. (2025) · Nano-Micro Letters · doi:10.1007/s40820-025-01843-9 · Cited by 36
Cox, A. R., Masschelin, P. M., Saha, P., Felix, J. B., Sharp, R., Lian, Z., Xia, Y., Chernis, N., Bader, D. A., Kim, K. H., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.019 · Cited by 33
Self-citationRen, Y., Cheng, L. L., Qie, R., Han, M., Kong, L., Yan, W., Li, Z., Li, Y., & Lei, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1187381 · Cited by 33
Saad, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612641 · Cited by 35
Xin, M., Bi, F., Wang, C., Huang, Y., Xu, Y., Liang, S., Cai, T., Xu, X., Dong, L., Li, T., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.005 · Cited by 35
Sun, A., Yang, H., Li, T., Luo, J., Zhou, L., Chen, R., Han, L., & Lin, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1368950 · Cited by 38
Nanotechnology in diabetes Management: Revolutionizing treatment and diagnostics
Yadav, D. K. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126117 · Cited by 35
Khalafi, M., Maleki, A. H., Ehsanifar, M., Symonds, M. E., & Rosenkranz, S. K. (2024) · Obesity Reviews · doi:10.1111/obr.13855 · Cited by 36
Tang, C., Zhao, H., Kong, L., Meng, F., Zhou, L., Lu, Z., & Lu, Y. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05670 · Cited by 34
Zhu, W., Chen, M., Wang, Y., Chen, Y., Zhang, Y., Wang, Y., Liu, P., & Li, P. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110711 · Cited by 35
Sullivan, V. K., Kim, H., Caulfield, L. E., Steffen, L. M., Selvin, E., & Rebholz, C. M. (2024) · Diabetes Care · doi:10.2337/dc23-2013 · Cited by 33
Wang, L., Wang, Q., Xiong, Y., Shi, W. F., & Xiao, Q. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s540103 · Cited by 41
Cardozo-Muñoz, J., Suárez, L. E. C., Prieto-Rodríguez, J. A., López-Vallejo, F., & Patiño-Ladino, O. J. (2022) · Molecules · doi:10.3390/molecules27103283 · Cited by 32
Lo, C. H., O’Connor, L. M., Loi, G. W. Z., Saipuljumri, E. N., Indajang, J., Lopes, K. M., Shirihai, O. S., Grinstaff, M. W., & Zeng, J. (2024) · ACS Nano · doi:10.1021/acsnano.3c09206 · Cited by 34
Zhang, Z., Lu, Y., Ye, M., Huang, W., Jin, L., Zhang, G., Ge, Y., Baghban, A., Zhang, Q., Wang, H., et al. (2023) · Journal of King Saud University - Computer and Information Sciences · doi:10.1016/j.jksuci.2023.101873 · Cited by 34
The flux of energy in critical illness and the obesity paradox
Jaitovich, A., & Hall, J. B. (2025) · Physiological Reviews · doi:10.1152/physrev.00029.2024 · Cited by 34
Cardiovascular Disease Risk Reduction and Body Mass Index
Samson, R., Ennezat, P. V., Jemtel, T. H. L., & Oparil, S. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01213-5 · Cited by 31
Emerging roles of olfactory receptors in glucose metabolism
Yang, Z., Cheng, J., Shang, P., Sun, J., & Yu, X. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.09.005 · Cited by 30
Weight Loss Programs: Why Do They Fail? A Multidimensional Approach for Obesity Management
Khattab, R. Y. (2024) · Current Nutrition Reports · doi:10.1007/s13668-024-00551-x · Cited by 36
Çetin, A., Donmez, A., Dalar, A., & Bildirici, İ. (2022) · Medicinal Chemistry Research · doi:10.1007/s00044-022-03005-7 · Cited by 29
Lu, Z., Zheng, Y., Zheng, J., Liang, Q., Zhen, Q., Cui, M., Yang, H., Wu, H., Tian, C., Zhu, K., et al. (2024) · Food & Function · doi:10.1039/d3fo05459d · Cited by 28
Challenges and opportunities in obesity: the role of adipocytes during tissue fibrosis
Zhang, Q., Lu, C., Lu, F., Liao, Y., Cai, J., & Gao, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1365156 · Cited by 28
Merovci, A., Finley, B., HANSIS-DIARTE, A. A., Neppala, S., Abdul‐Ghani, M. A., Cersósimo, E., Triplitt, C. L., & DeFronzo, R. A. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004199 · Cited by 36
Nano-Based Drug Delivery Systems for Managing Diabetes: Recent Advances and Future Prospects
Liu, M., Wang, R., Hoi, M. P. M., Wang, Y., Wang, S., Li, G., Vong, C. T., & Chong, C. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s508875 · Cited by 27
Identifying obesity subtypes: A review of studies utilising clinical biomarkers and genetic data
Abraham, A., & Yaghootkar, H. (2023) · Diabetic Medicine · doi:10.1111/dme.15226 · Cited by 27
Hateley, C., Olona, A., Halliday, L. J., Edin, M. L., Ko, J., Forlano, R., Terra, X., Lih, F. B., Beltrán‐Debón, R., Manousou, P., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105127 · Cited by 28
Metadata
- Authors
- Klein, S., Gastaldelli, A., Yki-Järvinen, H., & Scherer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- Istituto di Fisiologia Clinica (IT)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Klein, Samuel
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 34
- Issue
- 1
- Pages
- 11-20
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC8740746
- OpenAlex
- W4206513048
- Cited by
- 939
- References
- 112
- Citations by year
- 2026: 196 · 2025: 329 · 2024: 249 · 2023: 112 · 2022: 51
- FWCI
- 29.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 368 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Sigrid Juséliuksen Säätiö
- Inventiva Pharma
- National Institutes of Health (R01-DK099110, DK20579, RC2-DK118620, UL1TR002345, DK56341, R01-DK55758)
- Academy of Finland
- Eli Lilly and Company
- Gilead Sciences
- Janssen Pharmaceuticals
- Merck
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, type 2 diabetes, body mass index, beta-cell dysfunction, adipose tissue, insulin resistance, weight loss, diabetes pathogenesis
- MeSH terms
- Adipose Tissue, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
